Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 16, 2023

Total Value: $277M (100.0% shares, 0.0% debt)

Holdings (21)

QDEL QUIDELORTHO CORP 18.5%
Value $51.33M Shares 619,426 Share Price $82.86 * Est. Cost/Share $89.75 Unrealized @ Report Date -2.5%
EOLS EVOLUS INC 11.8%
Value $32.76M Shares 4,506,197 Share Price $7.27 * Est. Cost/Share $8.60 Unrealized @ Report Date +0.3%
ADMA ADMA BIOLOGICS INC 11.7%
Value $32.45M Shares 8,793,321 Share Price $3.69 Est. Cost/Share $2.19 Unrealized @ Report Date +69.4%
GLPG GALAPAGOS NV-SPON ADR 10.0%
Value $27.76M Shares 682,664 Share Price $40.66 Est. Cost/Share $40.07 Unrealized @ Report Date —
AMLX AMYLYX PHARMACEUTICALS INC 8.7%
Value $24.18M Shares 1,121,028 Share Price $21.57 * Est. Cost/Share $27.01 Unrealized @ Report Date 0.0%
MXCT MAXCYTE INC 6.6%
Value $18.21M Shares 3,966,916 Share Price $4.59 Est. Cost/Share $4.90 Unrealized @ Report Date -6.3%
XERS XERIS BIOPHARMA HOLDINGS INC 5.2%
Value $14.41M Shares 5,500,228 Share Price $2.62 * Est. Cost/Share $2.15 Unrealized @ Report Date +18.7%
— THIRD HARMONIC BIO INC 4.8%
Value $13.44M Shares 2,793,149 Share Price $4.81 Est. Cost/Share $4.24 Unrealized @ Report Date —
ATYR ATYR PHARMA INC 3.6%
Value $9.995M Shares 4,627,224 Share Price $2.16 Est. Cost/Share $2.19 Unrealized @ Report Date -0.4%
— X4 PHARMACEUTICALS, INC. 3.2%
Value $8.934M Shares 4,605,263 Share Price $1.94 Est. Cost/Share $1.94 Unrealized @ Report Date —
SCYX SCYNEXIS INC 3.1%
Value $8.692M Shares 2,946,346 Share Price $2.95 Est. Cost/Share $2.73 Unrealized @ Report Date +7.0%
XOMA XOMA CORP 2.4%
Value $6.6M Shares 349,399 Share Price $18.89 Est. Cost/Share $20.71 Unrealized @ Report Date -9.5%
RZLT REZOLUTE INC 2.2%
Value $6.084M Shares 3,072,476 Share Price $1.98 * Est. Cost/Share $3.88 Unrealized @ Report Date -47.0%
TELA TELA BIO INC 1.8%
Value $4.889M Shares 482,619 Share Price $10.13 Est. Cost/Share $10.23 Unrealized @ Report Date 0.0%
URGN UROGEN PHARMA LTD 1.7%
Value $4.642M Shares 448,508 Share Price $10.35 * Est. Cost/Share $7.43 Unrealized @ Report Date +48.4%
XGN EXAGEN INC 1.1%
Value $3.043M Shares 1,049,352 Share Price $2.90 Est. Cost/Share $9.86 Unrealized @ Report Date -71.1%
— GAMIDA CELL LTD 1.0%
Value $2.895M Shares 1,500,000 Share Price $1.93 Est. Cost/Share $1.93 Unrealized @ Report Date —
AVIR ATEA PHARMACEUTICALS INC 1.0%
Value $2.813M Shares 752,088 Share Price $3.74 Est. Cost/Share $4.03 Unrealized @ Report Date -7.1%
DCTH DELCATH SYSTEMS, INC. 0.8%
Value $2.098M Shares 378,787 Share Price $5.54 * Est. Cost/Share $6.27 Unrealized @ Report Date 0.0%
CSTL CASTLE BIOSCIENCES INC 0.5%
Value $1.262M Shares 91,978 Share Price $13.72 * Est. Cost/Share $23.67 Unrealized @ Report Date -14.4%
AYTU AYTU BIOPHARMA INC 0.3%
Value $756K Shares 472,369 Share Price $1.60 * Est. Cost/Share $1.96 Unrealized @ Report Date 0.0%